"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
NDTV
The WHO has issued an alert after "Substandard (contaminated)" Guaifenesin Syrup TG Syrup was found in the Marshall Islands and Micronesia.
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
The World Health Organisation has issued a 'WHO Medical Product Alert' after "Substandard (contaminated)" Guaifenesin Syrup TG Syrup was found in the Marshall Islands and Micronesia.
The manufacturer of the affected product is QP Pharma Chem Limited in Punjab. The marketer of the product is Trillium Pharma in Haryana, said WHO.
"Food And Drug Administration (FDA) of Punjab doubt that someone has duplicated the product (cough syrup) sent to Cambodia and then sold it in the Marshall Islands and Micronesia to defame the Government of India," said Sudhir Pathak, MD of the firm based in Dera Bassi, Punjab.
